A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)
Clinical trial NCT05619692 · COMPLETED
Trial details
- NCT number
- NCT05619692
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-29
- Primary completion
- 2024-06-05
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.